1 Study Coverage
1.1 Molecular Diagnostics in Infectious Disease Testing Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million) Introduction
1.2 Global Molecular Diagnostics in Infectious Disease Testing Outlook 2017 VS 2022 VS 2028
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size for the Year 2017-2028
1.2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size for the Year 2017-2028
1.3 Molecular Diagnostics in Infectious Disease Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Molecular Diagnostics in Infectious Disease Testing in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Molecular Diagnostics in Infectious Disease Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Molecular Diagnostics in Infectious Disease Testing Market Dynamics
1.4.1 Molecular Diagnostics in Infectious Disease Testing Industry Trends
1.4.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers
1.4.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges
1.4.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Molecular Diagnostics in Infectious Disease Testing by Type
2.1 Molecular Diagnostics in Infectious Disease Testing Market Segment by Type
2.1.1 Polymerase Chain Reaction (PCR)
2.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
2.1.3 Microarrays
2.1.4 Next-Generation Sequencing (NGS)
2.1.5 Hybridization
2.1.6 Others
2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017, 2022 & 2028)
2.3 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2028)
2.4 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017, 2022 & 2028)
2.5 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2017-2028)
3 Molecular Diagnostics in Infectious Disease Testing by Application
3.1 Molecular Diagnostics in Infectious Disease Testing Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Academic Institutes
3.1.4 Laboratories
3.1.5 Others
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017, 2022 & 2028)
3.3 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2028)
3.4 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017, 2022 & 2028)
3.5 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2017-2028)
4 Global Molecular Diagnostics in Infectious Disease Testing Competitor Landscape by Company
4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Company
4.1.1 Top Global Molecular Diagnostics in Infectious Disease Testing Companies Ranked by Revenue (2021)
4.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Player (2017-2022)
4.2 Global Molecular Diagnostics in Infectious Disease Testing Concentration Ratio (CR)
4.2.1 Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Molecular Diagnostics in Infectious Disease Testing in 2021
4.2.3 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Molecular Diagnostics in Infectious Disease Testing Headquarters, Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million) Type
4.3.1 Global Molecular Diagnostics in Infectious Disease Testing Headquarters and Area Served
4.3.2 Global Molecular Diagnostics in Infectious Disease Testing Companies Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Molecular Diagnostics in Infectious Disease Testing Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Molecular Diagnostics in Infectious Disease Testing Market Size by Company
4.5.1 Top Molecular Diagnostics in Infectious Disease Testing Players in United States, Ranked by Revenue (2021)
4.5.2 United States Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2020, 2021 & 2022)
5 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region
5.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2017-2028)
5.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region: 2017-2022
5.2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth 2017-2028
6.1.2 North America Molecular Diagnostics in Infectious Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth 2017-2028
6.3.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth 2017-2028
6.4.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Details
7.1.2 Abbott Business Overview
7.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Introduction
7.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.1.5 Abbott Recent Development
7.2 BD
7.2.1 BD Company Details
7.2.2 BD Business Overview
7.2.3 BD Molecular Diagnostics in Infectious Disease Testing Introduction
7.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.2.5 BD Recent Development
7.3 BioMerieux
7.3.1 BioMerieux Company Details
7.3.2 BioMerieux Business Overview
7.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Introduction
7.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.3.5 BioMerieux Recent Development
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Details
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Introduction
7.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.4.5 Thermo Fisher Scientific Recent Development
7.5 Roche
7.5.1 Roche Company Details
7.5.2 Roche Business Overview
7.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Introduction
7.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.5.5 Roche Recent Development
7.6 Siemens
7.6.1 Siemens Company Details
7.6.2 Siemens Business Overview
7.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Introduction
7.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.6.5 Siemens Recent Development
7.7 Veridex
7.7.1 Veridex Company Details
7.7.2 Veridex Business Overview
7.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Introduction
7.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.7.5 Veridex Recent Development
7.8 Luminex
7.8.1 Luminex Company Details
7.8.2 Luminex Business Overview
7.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Introduction
7.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.8.5 Luminex Recent Development
7.9 GenMark Diagnostics
7.9.1 GenMark Diagnostics Company Details
7.9.2 GenMark Diagnostics Business Overview
7.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Introduction
7.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.9.5 GenMark Diagnostics Recent Development
7.10 Qiagen
7.10.1 Qiagen Company Details
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Introduction
7.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.10.5 Qiagen Recent Development
7.11 Genomix Biotech
7.11.1 Genomix Biotech Company Details
7.11.2 Genomix Biotech Business Overview
7.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Introduction
7.11.4 Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.11.5 Genomix Biotech Recent Development
7.12 BioTheranostics
7.12.1 BioTheranostics Company Details
7.12.2 BioTheranostics Business Overview
7.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Introduction
7.12.4 BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2017-2022)
7.12.5 BioTheranostics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
